Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€223.95

€223.95

-0.470%
-1.05
-0.470%
€250.00
 
19.07.24 / Tradegate WKN: 866197 / Symbol: DHR / Name: Danaher / Stock / Machinery, Equipment & Components / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Danaher Corp. Stock

Danaher Corp. shows a slight decrease today, losing -€1.050 (-0.470%) compared to yesterday.
The stock is an absolute favorite of our community with 44 Buy predictions and no Sell predictions.
As a result the target price of 250 € shows a slightly positive potential of 11.63% compared to the current price of 223.95 € for Danaher Corp..
For the coming years our community has positive and negative things to say abot the Danaher Corp. stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Debt" there were negative voices in the community.

Pros and Cons of Danaher Corp. in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Danaher Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Danaher Corp. -0.470% -1.038% -5.106% 2.871% 6.745% -6.881% 76.311%
Stanley Black & Decker Inc. -0.400% -1.431% 2.540% -9.613% -10.823% -52.933% -37.970%
Parker-Hannifin -0.860% 1.500% 5.810% 38.995% 19.437% 103.826% 229.908%
IDEX Corp. -1.850% -0.560% -1.113% -1.061% -4.968% -1.323% -

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

Danaher Corporation, with the US trading symbol DHR, is a major player in the Machinery, Equipment & Components industry. After evaluating its financial statements, one can generally conclude that the company has shown remarkable growth and strength over the past few years. With a solid balance sheet and consistent cash flow generation, Danaher appears to be positioned well for future growth. However, as with any company, there are certain aspects that warrant close attention.

Pros

Earnings growth: Net income has shown an upward trend, growing from $3.65 billion in 2020 to $7.21 billion in 2022. This is indicative of the company's financial strength and profitability.

Comments

Prediction Buy
Perf. (%) -2.44%
Target price 260.000
Change
Ends at 17.07.25

Danaher Corporation, a diversified conglomerate, has been steadily impressing investors with its strong performance. The recent news highlights the company's ability to adapt and innovate, positioning it well for future growth. Danaher's recent acquisition of Cepheid, a leading provider of diagnostic tests, has expanded its reach in the healthcare sector, and the FDA's approval of Cepheid's rapid hepatitis C test is a testament to the company's technological prowess. Additionally, the company's solid valuation metrics, such as a P/E ratio of 28.5 and a P/B ratio of 3.9, suggest that it is reasonably priced, making it an attractive investment opportunity. While the stock has experienced a slight dip recently, I believe this is a temporary market fluctuation, and the long-term prospects for Danaher remain bright. With its diversified portfolio, innovative products, and strong financial position, Danaher appears to be well-positioned to continue its impressive growth trajectory. As an investor, I am cautiously optimistic about Danaher's future and would consider it a solid addition to my portfolio.
Show more

Prediction Buy
Perf. (%) -2.44%
Target price 250.000
Change
Ends at 17.07.25

Danaher Corp. is a well-diversified industrial conglomerate with a strong track record of growth and innovation. The company's recent acquisition of Cepheid, a leading provider of molecular diagnostic tests, has further strengthened its position in the healthcare segment. The FDA's approval of Cepheid's rapid test for hepatitis C is a positive development that could drive future growth. While Danaher's stock has experienced a bit of a slump lately, I believe the company's solid fundamentals and promising pipeline of new products make it a compelling investment opportunity. The stock's current price of $231.3 seems like a reasonable entry point, and I'm optimistic about its potential to reach a target price of $250 in the near future. Danaher's management team has a proven track record of executing strategic acquisitions and driving operational efficiency, which gives me confidence in the company's ability to navigate the current market environment. Overall, I believe Danaher is a well-run company with a diverse portfolio of businesses and a promising future, making it a smart choice for investors looking to capitalize on the healthcare and industrial sectors.
Show more

Prediction Buy
Perf. (%) -2.44%
Target price 250.000
Change
Ends at 17.07.25

After reviewing the latest news and analyses on Danaher Corp. (DHR), I'm feeling pretty optimistic about this stock. The company's recent upgrade to a Zacks Rank #2 (Buy) is a promising sign, and the approval of Cepheid's point-of-care hepatitis C test suggests Danaher is making strategic moves to strengthen its product portfolio. While the stock may be on a bit of a losing streak lately, I believe the long-term prospects are still solid. Danaher has a proven track record of innovation and operational excellence, and with its diverse range of products and services, the company seems well-positioned to weather any market turbulence. Think of it like a sturdy oak tree - it may sway a bit in the wind, but its deep roots keep it standing tall. Overall, I believe Danaher is a stock worth considering for your portfolio, and I'm setting a target price of $250 based on the company's strong fundamentals and growth potential.
Show more